Allergy Therapeutics shares jump after US vaccine approval
06:15 EDT 3 Aug 2012 | Proactive Investors
Shares in Allergy Therapeutics (LON:AGY) jumped after the US Food and Drug Administration (FDA) lifted its five-year hold on the company’s clinical development programme for a grass pollen vaccine. The pharmaceutical company will now push ahead..
Original Article: Allergy Therapeutics shares jump after US vaccine approval
More From BioPortfolio on "Allergy Therapeutics shares jump after US vaccine approval"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
